The role of TXNRD2 in the glaucoma pathogenesis has been evidenced through anexperimental glaucoma model in which overexpression of thioredoxin 2, the substrateof thioredoxin reductase 2, increased retinal ganglion cell survival(29). This evidence concerns the gene TXN2 and glaucoma.